Michael Bookman is CHIEF LEGAL OFFICER, SECRETARY of Immuneering Corp. Currently has a direct ownership of 3,850 shares of IMRX, which is worth approximately $8,008. The most recent transaction as insider was on Mar 15, 2024, when has been sold 1,448 shares (Class A Common Stock) at a price of $1.62 per share, resulting in proceeds of $2,345. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.85K
0% 3M change
60.28% 12M change
Total Value Held $8,008

Michael Bookman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2024
BUY
Grant, award, or other acquisition
$2,345 $1.62 p/Share
1,448 Added 27.33%
3,850 Class A Common Stock
May 17 2022
BUY
Open market or private purchase
$4,880 $4.88 p/Share
1,000 Added 29.39%
2,402 Class A Common Stock
Aug 03 2021
BUY
Open market or private purchase
$21,030 $15.0 p/Share
1,402 Added 50.0%
1,402 Class A Common Stock

Also insider at

FREQ
Frequency Therapeutics, Inc. Healthcare
MB

Michael Bookman

CHIEF LEGAL OFFICER, SECRETARY
Lexington, MA

Track Institutional and Insider Activities on IMRX

Follow Immuneering Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMRX shares.

Notify only if

Insider Trading

Get notified when an Immuneering Corp insider buys or sells IMRX shares.

Notify only if

News

Receive news related to Immuneering Corp

Track Activities on IMRX